# PubMed record PMID 41337724

> PeptideScanner retained PubMed bibliographic metadata for PMID 41337724 at 2026-07-30T18:19:18.413Z. PubMed recorded a metadata revision date of 2025-12-03 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41337724-maridebart-cafraglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-12-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41337724-maridebart-cafraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41337724-maridebart-cafraglutide-v1.json
- Content SHA-256: `e985bf91c1136a9f94400f5ac15691c65f81d0ba1ec958a790b7fecce2484ebf`

## Claims and source pins

### Headline

PubMed record PMID 41337724 ([`pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3`](#source-pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41337724 at 2026-07-30T18:19:18.413Z. PubMed recorded a metadata revision date of 2025-12-03 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3`](#source-pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41337724 at 2026-07-30T18:19:18.413Z. PubMed recorded a metadata revision date of 2025-12-03 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3`](#source-pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3`](#source-pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3))

## Sources

<a id="source-pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3"></a>
- **PubMed record PMID 41337724 · retained source version 1:2025-12-03:current:a4eeac53f0c35b4e52f5f0374d742523825106ce3160700deeaa8759f03915dc** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41337724/) (`pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 41337724." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41337724-maridebart-cafraglutide-v1.json SHA-256: e985bf91c1136a9f94400f5ac15691c65f81d0ba1ec958a790b7fecce2484ebf.